Mari Haramoto

438 total citations
8 papers, 385 citations indexed

About

Mari Haramoto is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Mari Haramoto has authored 8 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Oncology. Recurrent topics in Mari Haramoto's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Mari Haramoto is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Chemical Synthesis and Analysis (2 papers) and Toxin Mechanisms and Immunotoxins (2 papers). Mari Haramoto collaborates with scholars based in Japan and United States. Mari Haramoto's co-authors include Masayuki Kohno, Koji Kawakami, Koji Ohara, Tomohisa Horibe, Nobuhiko Miwa, Hiroya Takada, Li Xiao, Norio Muto, Hideki Tatemoto and Oumi Nakajima and has published in prestigious journals such as Biochemical and Biophysical Research Communications, European Journal of Cancer and Molecular Cancer Therapeutics.

In The Last Decade

Mari Haramoto

8 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mari Haramoto Japan 8 193 104 93 61 42 8 385
Miriam Buttacavoli Italy 9 195 1.0× 73 0.7× 120 1.3× 52 0.9× 24 0.6× 14 448
Cristian V. A. Munteanu Romania 12 253 1.3× 38 0.4× 55 0.6× 25 0.4× 41 1.0× 46 441
Nianhuan Yao United States 11 253 1.3× 121 1.2× 17 0.2× 35 0.6× 20 0.5× 17 415
Ahil N. Ganesh Canada 11 211 1.1× 53 0.5× 51 0.5× 38 0.6× 29 0.7× 13 481
Jiaqi Zhou China 13 219 1.1× 65 0.6× 20 0.2× 125 2.0× 35 0.8× 33 390
Di Bei United States 12 153 0.8× 54 0.5× 20 0.2× 73 1.2× 57 1.4× 16 448
Juntao Yu China 11 621 3.2× 283 2.7× 56 0.6× 77 1.3× 71 1.7× 16 825
Sander van Kasteren United Kingdom 8 219 1.1× 175 1.7× 26 0.3× 43 0.7× 31 0.7× 10 346

Countries citing papers authored by Mari Haramoto

Since Specialization
Citations

This map shows the geographic impact of Mari Haramoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Haramoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Haramoto more than expected).

Fields of papers citing papers by Mari Haramoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Haramoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Haramoto. The network helps show where Mari Haramoto may publish in the future.

Co-authorship network of co-authors of Mari Haramoto

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Haramoto. A scholar is included among the top collaborators of Mari Haramoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Haramoto. Mari Haramoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yang, Liying, Tomohisa Horibe, Masayuki Kohno, et al.. (2011). Targeting Interleukin-4 Receptor α with Hybrid Peptide for Effective Cancer Therapy. Molecular Cancer Therapeutics. 11(1). 235–243. 33 indexed citations
2.
Horibe, Tomohisa, Masayuki Kohno, Mari Haramoto, Koji Ohara, & Koji Kawakami. (2011). Designed hybrid TPR peptide targeting Hsp90 as a novel anticancer agent. Journal of Translational Medicine. 9(1). 8–8. 53 indexed citations
3.
Tada, Noriko, Tomohisa Horibe, Mari Haramoto, et al.. (2011). A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity. Biochemical and Biophysical Research Communications. 407(2). 383–388. 32 indexed citations
4.
Kohno, Masayuki, Tomohisa Horibe, Mari Haramoto, et al.. (2010). A novel hybrid peptide targeting EGFR-expressing cancers. European Journal of Cancer. 47(5). 773–783. 64 indexed citations
5.
Kohno, Masayuki, Mari Haramoto, Oumi Nakajima, et al.. (2010). Antedrug Budesonide by Intrapulmonary Treatment Attenuates Bleomycin-Induced Lung Injury in Rats with Minimal Systemic Adverse Effects. Biological and Pharmaceutical Bulletin. 33(7). 1206–1211. 9 indexed citations
6.
Muto, Norio, Mari Haramoto, Hideki Tatemoto, et al.. (2008). Isolation of Apoptosis- and Differentiation-Inducing Substances toward Human Promyelocytic Leukemia HL-60 Cells from Leaves ofJuniperus taxifolia. Bioscience Biotechnology and Biochemistry. 72(2). 477–484. 58 indexed citations
7.
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miriam Buttacavoli Breakdown of academic impact, for papers by Cristian V. A. Munteanu Breakdown of academic impact, for papers by Nianhuan Yao Breakdown of academic impact, for papers by Ahil N. Ganesh Breakdown of academic impact, for papers by Jiaqi Zhou Breakdown of academic impact, for papers by Di Bei Breakdown of academic impact, for papers by Juntao Yu Breakdown of academic impact, for papers by Sander van Kasteren
Rankless by CCL
2026